[1]
|
H. V. Hogerzeil, M. R. Couper and R. Gray, “Guidelines for Drug Donations,” British Medical Journal (BMJ), Vol. 314, 1997, p. 737. doi: 10.1136/bmj.314.7082.737
|
[2]
|
“Australian Guidelines for Drug Donations to Developing Countries,” Amendments Endorsed, November 2000
|
[3]
|
“Guidelines for Drug Donations,” WHO/EDM/PAR/99.4 Revised, 1999.
|
[4]
|
E. Hoen and C. Hodgkin, “Harmful Use of Donated Veterinary Drug,” Lancet, Vol. 2, 1993, pp. 308-209.
doi: 10.1016/0140-6736(93)91856-H
|
[5]
|
B. Snell, “Inappropriate Drug Donations: The Need for Reform,” Lancet, Vol. 758, 2001, p. 9281.
|
[6]
|
M. R. Riech, “Pharmaceutical Donations: Players, Processes, and Products, “Assessment of US Pharmaceutical Donations, 1999.
|
[7]
|
Pharmacien Sans Fronteire Comite International, “Accessibility for Everyone to Quality Pharmaceutical Care,” Press Release, 2004.
|
[8]
|
Srilanka Ministry of Health, “Most Tsunami Drug Donations Were Useless and Dangerous (Report),” The Sunday times online, Vol. 41, No. 34, 2007, pp. 1391-0531.
|
[9]
|
World Health Organization, “Think before You Send,” WHO Regional Office for Europe, Press Release, Zagreb, 1999.
|
[10]
|
WHO/EDM/PAR. (1998) “Guidelines for Safe Disposal of Unwanted Pharmaceuticals in and after Emergencies,” Geneva: World Health Organization. WHO/EDM/PAR/ 98.2
|
[11]
|
M. Bonati, “Drug Donations to Bosnia-Herzegovina Are Often Inappropriate,” British Medical Journal (BMJ), Vol. 313, 1996, pp. 87-90. doi:10.1136/bmj.313.7063.1011b
|
[12]
|
J. A. Patricia and M. R. Riech, “PVO Pharmaceutical Donations: Making the Incentive Fit the Need,” Journal of Research in Pharmaceutical Economics, Vol. 804, 1990, pp. 40-60.
|